# SGLT2-inhibitors on PC-AKI

> **NCT06491953** · — · ACTIVE_NOT_RECRUITING · sponsor: **Shenyang Northern Hospital** · enrollment: 3600 (estimated)

## Conditions studied

- Impact of SGLT2-inhibitors on PC-AKI in ACS Patients Receiving Invasive Strategy

## Interventions

- **DRUG:** SGLT-2 inhibitors

## Key facts

- **NCT ID:** NCT06491953
- **Lead sponsor:** Shenyang Northern Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2025-05-30
- **Final completion:** 2026-05-28
- **Target enrollment:** 3600 (ESTIMATED)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06491953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06491953, "SGLT2-inhibitors on PC-AKI". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06491953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*